CCO Oncology Podcast

Podcast autorstwa Clinical Care Options

Kategorie:

185 Odcinki

  1. Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations

    Opublikowany: 10.01.2022
  2. Targeted Treatment Options for Patients With AML and FLT3 or IDH1/2 Mutations

    Opublikowany: 10.01.2022
  3. An Overview of AML and Treatment Strategies for Patients Unfit for Intensive Therapy

    Opublikowany: 10.01.2022
  4. Managing Lower-Risk Myelodysplastic Syndrome: Nursing Implications

    Opublikowany: 22.12.2021
  5. Managing Higher-Risk and Relapsed/Refractory Myelodysplastic Syndromes: Nursing Implications

    Opublikowany: 22.12.2021
  6. Key Factors Influencing Later-Line Treatment Selection for Patients With Metastatic Colorectal Cancer

    Opublikowany: 17.12.2021
  7. The Evolving Role of TKIs in First-line Treatment of Advanced HCC

    Opublikowany: 14.12.2021
  8. Expert Insight on Important Clinical Trial Data From ESGO 2021 Informing Treatment for Ovarian Cancer and Endometrial Cancers

    Opublikowany: 23.11.2021
  9. Experts Answer FAQs on Immunotherapy for Non-Small-Cell Lung Cancer

    Opublikowany: 23.11.2021
  10. Overcoming Acquired Resistance With Second-Generation TRK Inhibitors

    Opublikowany: 9.11.2021
  11. Role of TKIs in Nonadipocytic Soft Tissue Sarcoma and Advanced Osteosarcoma

    Opublikowany: 2.11.2021
  12. PARP Inhibitors in Pancreatic Cancer: Experts Discuss Importance of Testing for Biomarkers Along With Current Treatment Landscape

    Opublikowany: 26.10.2021
  13. Optimal Dosing Strategies With Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer

    Opublikowany: 21.10.2021
  14. First-Generation TRK Inhibitors: Clinical Evidence and Indications

    Opublikowany: 15.10.2021
  15. PARP Inhibitors in Ovarian Cancer: Experts Discuss Patient Cases and the Current Paradigm

    Opublikowany: 14.10.2021
  16. Counseling Patients and Caregivers on Prophylaxis Therapy for Severe Hemophilia A

    Opublikowany: 8.10.2021
  17. Rationale for NTRK Testing in Patients With Cancer

    Opublikowany: 8.10.2021
  18. Expert Answers to HCP Questions on Androgen Deprivation Therapy for Prostate Cancer

    Opublikowany: 7.10.2021
  19. Expert Insight on Important Clinical Trial Data From ESMO 2021 Informing Treatment for Endometrial and Ovarian Cancer

    Opublikowany: 29.09.2021
  20. Expert Insight on New Evidence Poised to Change the Treatment Landscape in Melanoma

    Opublikowany: 28.09.2021

5 / 10

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

Visit the podcast's native language site